Higinio Dopeso Selected Research

Higinio Dopeso Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 09/2009
10	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 04/2010
6	Colonic Neoplasms (Colon Cancer) 01/2017 - 10/2009
4	Neoplasm Metastasis (Metastasis) 11/2022 - 11/2014
3	Microsatellite Instability 04/2013 - 10/2009
2	Carcinogenesis 01/2022 - 09/2009
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 04/2013
2	Hypoxia (Hypoxemia) 01/2018 - 11/2014
1	Disease Progression 11/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Residual Neoplasm 01/2022
1	Plasmacytoma 01/2020
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Lymphatic Metastasis 01/2017
1	Chromosomal Instability (Chromosome Stability) 04/2012

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2009
3	Messenger RNA (mRNA)IBA 01/2021 - 10/2009
2	Transcription Factors (Transcription Factor)IBA 11/2022 - 01/2022
2	Calcibiotic Root Canal SealerIBA 11/2022 - 04/2012
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017 - 09/2009
2	AgarIBA 01/2017 - 01/2012
2	Myosin Type I (Myosin IA)IBA 04/2013 - 01/2012
1	ChromatinIBA 11/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Verteporfin (Visudyne)FDA Link 01/2022
1	Biological ProductsIBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Competitive Endogenous RNAIBA 01/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	LigandsIBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	EphA1 Receptor (Eph Receptor)IBA 01/2017
1	acifluorfen (Blazer)IBA 08/2015
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 08/2015
1	Small Interfering RNA (siRNA)IBA 08/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2015
1	Protoporphyrinogen Oxidase (Protox)IBA 08/2015
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 11/2014
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 11/2014
1	CateninsIBA 11/2014
1	Monomeric GTP-Binding ProteinsIBA 11/2014
1	Decitabine FDA Link 04/2013
1	Cycloheximide (Cicloheximide)IBA 04/2013
1	villinIBA 04/2012
1	CarcinogensIBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 04/2010
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2010
1	ErbB Receptors (EGF Receptor)IBA 10/2009
1	Adenosine (Adenocard)FDA LinkGeneric 10/2009

Therapy/Procedure

3	Therapeutics 01/2022 - 04/2010
1	Hyperthermic Intraperitoneal Chemotherapy 01/2022